Key result
Direct oral anticoagulants reduced thrombin generation parameters with significant interindividual variability compared with neat plasma.
Why the study?
Does spiking plasma with direct oral anticoagulants affect thrombin generation parameters and demonstrate interindividual variability?
Does spiking plasma with direct oral anticoagulants affect thrombin generation parameters and demonstrate interindividual variability?
Thrombin generation assays can measure the anticoagulation effect of DOACs, revealing significant interindividual pharmacodynamic variability that may impact efficacy and bleeding risk.
Answers are grounded in this paper and cite their sources.
Thrombin generation assays may detect DOAC variability in animal plasma; leaves open clinical translation and human applicability.
: Direct oral anticoagulants (DOACs) are increasingly being used, primarily due to their drug stability and patient convenience. Although these drugs have been evaluated to be well tolerated in numerous clinical trials, their impact on in-vivo anticoagulation effect, variability and therapeutic drug level remains unknown. Hence, we aim to study the effect and variability of DOACs on thrombin generation via the calibrated automated thrombogram. Anonymized coagulation specimens from outpatients on warfarin were collected. Pooled normal plasma samples were spiked with increasing concentrations of dabigatran, rivaroxaban and apixaban. Similarly, plasma samples with normal coagulation profiles were spiked with two concentrations each of dabigatran, rivaroxaban and apixaban. Thrombin generation via calibrated automated thrombogram was run using the above samples and compared with a dataset of normal controls. Increasing international normalized ratio was associated with a reduction of endogenous thrombin potential (ETP) and thrombin peak and increasing lag time. Factor Xa inhibitors produced a flattened thrombin generation curve with a reduction of thrombin peak and relative preservation of ETP. Direct thrombin inhibitors produced a reduction of both ETP and thrombin peak and increasing lag time. Seventy-one citrated plasma samples (26 dabigatran, 21 rivaroxaban and 24 apixaban) were evaluated. The two concentrations produced a reduction of thrombin generation parameters with significant interindividual variability compared with neat plasma of 35-93, 13-31 and 18-71% and for dabigatran, rivaroxaban and apixaban, respectively. Thrombin generation can measure the anticoagulation effect of commonly used DOACs, with each drug having a unique thrombin generation profile. The variability noted using the same concentration suggests significant interindividual pharmacodynamic differences, which maybe relevant with respect to efficacy as well as bleeding side effects. Further delineation of the modifiers of interindividual differences is required in the in-vivo setting.
No takes yet. Share an insight, caveat, or question.
Rigano et al. (2017) studied Normal coagulation profiles (n=71). Direct oral anticoagulants (dabigatran, rivaroxaban, apixaban) vs. Neat plasma / normal controls was evaluated on Thrombin generation parameters (endogenous thrombin potential, thrombin peak, and lag time). Direct oral anticoagulants reduced thrombin generation parameters with significant interindividual variability compared with neat plasma.
Synapse has enriched 10 related papers. Consider them for comparative context: